文献速递帕金森病与运动障碍认知障碍与痴呆

特发性快速眼动睡眠行为障碍与帕金森病的言语生物标志物

Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease.
PubMed 文献 · Ann Neurol · 2021-05-07

这项多语言多中心研究对448名受试者(150例特发性快速眼动睡眠行为障碍、149例早期帕金森病、149名健康对照)进行简单语音录音和自动声学分析,发现两组患者复合构音障碍指数均显著异常,但仅帕金森病在盲法主观分析中可被区分;12个月随访显示两组言语损害轻微进展。自动言语分析可能作为帕金森综合征的辅助生物标志物。

要点

  • 复合构音障碍指数可区分特发性快速眼动睡眠行为障碍与健康对照。
  • 单音调可区分特发性快速眼动睡眠行为障碍与健康对照。
  • 自动言语分析或有助于评估疾病进展和治疗干预。

核心结论

  • 自动言语分析可能为帕金森综合征提供有用的辅助生物标志物,用于评估疾病进展和治疗干预。

研究设计与样本

  • 多中心研究覆盖捷克语、英语、德语、法语和意大利语,在欧洲和北美7个中心进行。
  • 共纳入448名参与者(337名男性),包括150例特发性快速眼动睡眠行为障碍、149例帕金森病和149名健康对照。
  • 350名参与者完成了12个月随访。
  • 开发了针对7种运动减退性构音障碍特征的全自动声学定量评估方法。

主要发现

  • 未发现语言差异影响临床帕金森表型。
  • 与健康对照相比,特发性快速眼动睡眠行为障碍组(p=0.002)和帕金森病组(p<0.001)的复合构音障碍指数均显著异常。
  • 仅帕金森病组在盲法主观分析中可被区分(p<0.001)。
  • 帕金森病组与健康对照在单音调(p<0.001)、停顿延长(p<0.001)和辅音不精确(p=0.03)上存在显著组间差异。
  • 仅单音调能区分特发性快速眼动睡眠行为障碍患者与健康对照(p=0.004)。

临床怎么用

  • 自动言语分析可作为帕金森综合征的辅助生物标志物,用于评估疾病进展和治疗干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This multilanguage study used simple speech recording and high-end pattern analysis to provide sensitive and reliable noninvasive biomarkers of prodromal versus manifest α-synucleinopathy in patients with idiopathic rapid eye movement sleep behavior disorder (iRBD) and early-stage Parkinson disease (PD). METHODS: We performed a multicenter study across the Czech, English, German, French, and Italian languages at 7 centers in Europe and North America. A total of 448 participants (337 males), including 150 with iRBD (mean duration of iRBD across language groups 0.5-3.4 years), 149 with PD (mean duration of disease across language groups 1.7-2.5 years), and 149 healthy controls were recorded; 350 of the participants completed the 12-month follow-up. We developed a fully automated acoustic quantitative assessment approach for the 7 distinctive patterns of hypokinetic dysarthria. RESULTS: No differences in language that impacted clinical parkinsonian phenotypes were found. Compared with the controls, we found significant abnormalities of an overall acoustic speech severity measure via composite dysarthria index for both iRBD (p = 0.002) and PD (p < 0.001). However, only PD (p < 0.001) was perceptually distinct in a blinded subjective analysis. We found significant group differences between PD and controls for monopitch (p < 0.001), prolonged pauses (p < 0.001), and imprecise consonants (p = 0.03); only monopitch was able to differentiate iRBD patients from controls (p = 0.004). At the 12-month follow-up, a slight progression of overall acoustic speech impairment was noted for the iRBD (p = 0.04) and PD (p = 0.03) groups. INTERPRETATION: Automated speech analysis might provide a useful additional biomarker of parkinsonism for the assessment of disease progression and therapeutic interventions. ANN NEUROL 2021;90:62-75.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Rusz J, Hlavnička J, Novotný M, et al. Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease. Ann Neurol. 2021. PMID: 33856074. doi:10.1002/ana.26085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。